ReP USP - Resultado da busca

Artigo de periodico
Capsaicin inspired hydroxamate hybrids as selective HDAC6 Inhibitors with antiproliferative activity in hematological malignancies (2026)
Borges, Lara Gimenez; Alves, Thais Nascimento de Oliveira; Vassiliades, Sandra Valeria; Carlos, Jorge Antonio Elias Godoy; Waitman, Karoline de Barros; Hilscher, Sebastian; Schutkowski, Mike; Sippl, Wolfgang; Tavares, Maurício Temotheo; Toledo, Mônica Franco Zannini Junqueira; Lotufo, Letícia Veras Costa; Kronenberger, Thales; Machado Neto, João Agostinho; Parise Filho, Roberto
Source: ACS Omega. Unidades: FCF, ICB, IQ
Subjects: NEOPLASIAS, DOENÇAS HEMATOLÓGICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Lara Gimenez et al. Capsaicin inspired hydroxamate hybrids as selective HDAC6 Inhibitors with antiproliferative activity in hematological malignancies. ACS Omega, v. 11, n. 5, p. 8415–8430, 2026Tradução . . Disponível em: https://dx.doi.org/10.1021/acsomega.5c11286. Acesso em: 23 abr. 2026.
APA
Borges, L. G., Alves, T. N. de O., Vassiliades, S. V., Carlos, J. A. E. G., Waitman, K. de B., Hilscher, S., et al. (2026). Capsaicin inspired hydroxamate hybrids as selective HDAC6 Inhibitors with antiproliferative activity in hematological malignancies. ACS Omega, 11( 5), 8415–8430. doi:10.1021/acsomega.5c11286
NLM
Borges LG, Alves TN de O, Vassiliades SV, Carlos JAEG, Waitman K de B, Hilscher S, Schutkowski M, Sippl W, Tavares MT, Toledo MFZJ, Lotufo LVC, Kronenberger T, Machado Neto JA, Parise Filho R. Capsaicin inspired hydroxamate hybrids as selective HDAC6 Inhibitors with antiproliferative activity in hematological malignancies [Internet]. ACS Omega. 2026 ; 11( 5): 8415–8430.[citado 2026 abr. 23 ] Available from: https://dx.doi.org/10.1021/acsomega.5c11286
Vancouver
Borges LG, Alves TN de O, Vassiliades SV, Carlos JAEG, Waitman K de B, Hilscher S, Schutkowski M, Sippl W, Tavares MT, Toledo MFZJ, Lotufo LVC, Kronenberger T, Machado Neto JA, Parise Filho R. Capsaicin inspired hydroxamate hybrids as selective HDAC6 Inhibitors with antiproliferative activity in hematological malignancies [Internet]. ACS Omega. 2026 ; 11( 5): 8415–8430.[citado 2026 abr. 23 ] Available from: https://dx.doi.org/10.1021/acsomega.5c11286
Artigo de periodico
Ouratein D, a biflavanone from Ouratea spectabilis, alleviates betacoronavirus infection by mitigating inflammation, lung damage and viral replication (2025)
Monteiro, Adelson Héric Alves ; Godoy, Mariana Ortiz de ; Oliva, Glaucius ; Guido, Rafael Victorio Carvalho
Source: Phytotherapy Research. Unidade: IFSC
Subjects: QUÍMICA MÉDICA, PLANEJAMENTO DE FÁRMACOS, COVID-19, PULMÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTEIRO, Adelson Héric Alves et al. Ouratein D, a biflavanone from Ouratea spectabilis, alleviates betacoronavirus infection by mitigating inflammation, lung damage and viral replication. Phytotherapy Research, v. 39, n. 5, p. 2180-2196, 2025Tradução . . Disponível em: https://doi.org/10.1002/ptr.8462. Acesso em: 23 abr. 2026.
APA
Monteiro, A. H. A., Godoy, M. O. de, Oliva, G., & Guido, R. V. C. (2025). Ouratein D, a biflavanone from Ouratea spectabilis, alleviates betacoronavirus infection by mitigating inflammation, lung damage and viral replication. Phytotherapy Research, 39( 5), 2180-2196. doi:10.1002/ptr.8462
NLM
Monteiro AHA, Godoy MO de, Oliva G, Guido RVC. Ouratein D, a biflavanone from Ouratea spectabilis, alleviates betacoronavirus infection by mitigating inflammation, lung damage and viral replication [Internet]. Phytotherapy Research. 2025 ; 39( 5): 2180-2196.[citado 2026 abr. 23 ] Available from: https://doi.org/10.1002/ptr.8462
Vancouver
Monteiro AHA, Godoy MO de, Oliva G, Guido RVC. Ouratein D, a biflavanone from Ouratea spectabilis, alleviates betacoronavirus infection by mitigating inflammation, lung damage and viral replication [Internet]. Phytotherapy Research. 2025 ; 39( 5): 2180-2196.[citado 2026 abr. 23 ] Available from: https://doi.org/10.1002/ptr.8462
Artigo de periodico
A successful UN High-Level Meeting on antimicrobial resistance must build on the 2023 UN High-Level Meeting on tuberculosis (2024)
Cirillo, Daniela; Anthony, Richard; Gagneux, Sebastien; Horsburgh Jr, C Robert; Hasan, Rumina; Darboe, Saffiatou; Laniado-Laborin, Rafael; Probandari, Ari; Tukvadze, Nestani; Arcêncio, Ricardo Alexandre ; Bimba, John S.; Brighenti, Susanna; Chesov, Dumitru; Chiang, Chen-Yuan; Kalmambetova, Gulmira; Knight, Gwenan; Konstantynovska, Olha; Kruse, Alexandra; Lange, Christoph; Mayanja-Kizza, Harriet; McBryde, Emma; Min, Jinsoo; Sánchez-Montalvá, Adrián; Sulis, Giorgia; Tsogt, Bazarragchaa; Van Der Walt, Martie; Yeboah-Manu, Dorothy; Hauser, Janika
Source: The Lancet Global Health. Unidade: EERP
Subjects: TUBERCULOSE, ANTIBIÓTICOS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CIRILLO, Daniela et al. A successful UN High-Level Meeting on antimicrobial resistance must build on the 2023 UN High-Level Meeting on tuberculosis. The Lancet Global Health, v. 12, n. 8, p. e1225-e1226, 2024Tradução . . Disponível em: https://doi.org/10.1016/S2214-109X(24)00229-8. Acesso em: 23 abr. 2026.
APA
Cirillo, D., Anthony, R., Gagneux, S., Horsburgh Jr, C. R., Hasan, R., Darboe, S., et al. (2024). A successful UN High-Level Meeting on antimicrobial resistance must build on the 2023 UN High-Level Meeting on tuberculosis. The Lancet Global Health, 12( 8), e1225-e1226. doi:10.1016/S2214-109X(24)00229-8
NLM
Cirillo D, Anthony R, Gagneux S, Horsburgh Jr CR, Hasan R, Darboe S, Laniado-Laborin R, Probandari A, Tukvadze N, Arcêncio RA, Bimba JS, Brighenti S, Chesov D, Chiang C-Y, Kalmambetova G, Knight G, Konstantynovska O, Kruse A, Lange C, Mayanja-Kizza H, McBryde E, Min J, Sánchez-Montalvá A, Sulis G, Tsogt B, Van Der Walt M, Yeboah-Manu D, Hauser J. A successful UN High-Level Meeting on antimicrobial resistance must build on the 2023 UN High-Level Meeting on tuberculosis [Internet]. The Lancet Global Health. 2024 ; 12( 8): e1225-e1226.[citado 2026 abr. 23 ] Available from: https://doi.org/10.1016/S2214-109X(24)00229-8
Vancouver
Cirillo D, Anthony R, Gagneux S, Horsburgh Jr CR, Hasan R, Darboe S, Laniado-Laborin R, Probandari A, Tukvadze N, Arcêncio RA, Bimba JS, Brighenti S, Chesov D, Chiang C-Y, Kalmambetova G, Knight G, Konstantynovska O, Kruse A, Lange C, Mayanja-Kizza H, McBryde E, Min J, Sánchez-Montalvá A, Sulis G, Tsogt B, Van Der Walt M, Yeboah-Manu D, Hauser J. A successful UN High-Level Meeting on antimicrobial resistance must build on the 2023 UN High-Level Meeting on tuberculosis [Internet]. The Lancet Global Health. 2024 ; 12( 8): e1225-e1226.[citado 2026 abr. 23 ] Available from: https://doi.org/10.1016/S2214-109X(24)00229-8

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Grupo de pesquisa

Funding Agencies

Non normalized affiliation

Countries of institutions of collaboration